| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/04/2011 | WO2011093465A1 Transformation plasmid |
| 08/04/2011 | WO2011093365A1 Nitrogenated heterocyclic compound |
| 08/04/2011 | WO2011093097A1 Anti-dll3 antibody |
| 08/04/2011 | WO2011092840A1 Method for manufacturing polymethoxyflavones that are highly stable over time and have reduced residual pesticide levels |
| 08/04/2011 | WO2011092675A2 Molecular complex for targeting antigens towards cells comprising antigens and uses thereof for vaccination |
| 08/04/2011 | WO2011092505A1 S100 protein binding interaction inhibitors |
| 08/04/2011 | WO2011092469A1 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy |
| 08/04/2011 | WO2011092295A2 Novel radioimmunoconjugates and uses thereof |
| 08/04/2011 | WO2011092273A1 Treatment of gist with masitinib |
| 08/04/2011 | WO2011092198A1 5-alkynyl-pyrimidines |
| 08/04/2011 | WO2011092197A1 5-alkynyl pyrimidines and their use as kinase inhibitors |
| 08/04/2011 | WO2011092120A1 6,7- dihydroimidazo [1,5-a] pyrazin-8 (5h) - one derivatives as protein kinase modulators |
| 08/04/2011 | WO2011092088A1 Sulfonamido derivatives of 3,4-diarylpyrazoles as protein kinase inhibitors |
| 08/04/2011 | WO2011091973A1 5-nitro-8-hydroxyquinolines as inhibitors of cathepsin b |
| 08/04/2011 | WO2011091778A1 Production and use of antibacterial, antiproliferative, and antiphytopathogenic benzanthracenes |
| 08/04/2011 | WO2011091719A1 Crystalline hydrates of alkyl acyl acetaldehyde sulfite, preparation methods and uses thereof |
| 08/04/2011 | WO2011091716A1 Epidermal growth factor receptor variant |
| 08/04/2011 | WO2011067356A3 Polymorphs of a mek inhibitor |
| 08/04/2011 | WO2011067348A3 Mek inhibitor salts and solvates thereof |
| 08/04/2011 | WO2011041729A3 Compounds as lysophosphatidic acid receptor antagonists |
| 08/04/2011 | WO2011041613A3 Combination immunotherapy for the treatment of cancer |
| 08/04/2011 | WO2011035143A3 Methods and compositions for inhibiting rho-mediated diseases and conditions |
| 08/04/2011 | WO2011032000A9 Method for protection of antimicrobial and anticancer drugs from inactivation by nitric oxide |
| 08/04/2011 | WO2011031073A3 Novel tetra-aza macrocyclic compound, method for preparing same, and use thereof |
| 08/04/2011 | WO2011028947A3 Heterocyclic compounds for the inhibition of pask |
| 08/04/2011 | US20110191872 Method for the humanization of antibodies and humanized antibodies thereby obtained |
| 08/04/2011 | US20110191868 Methods for identification and use of agents targeting cancer stem cells |
| 08/04/2011 | US20110191865 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 08/04/2011 | US20110190623 Thermally-activatable liposome compositions and methods for imaging, diagnosis and therapy |
| 08/04/2011 | US20110190400 Novel Compounds for Treatment of Malignant Tumors |
| 08/04/2011 | US20110190399 Curcumin nanoparticles and methods of producing the same |
| 08/04/2011 | US20110190391 Ferrocene derivatives with anticancer activity |
| 08/04/2011 | US20110190390 Methods and materials for treating pancreatic cancer |
| 08/04/2011 | US20110190388 Ursolic acid derivative and pharmaceutical composition thereof |
| 08/04/2011 | US20110190386 Aptamer Inhibitors of Osteopontin and Methods of Use Thereof |
| 08/04/2011 | US20110190384 siRNA Specific to WT1 17AA(-)Isoform and Use Thereof |
| 08/04/2011 | US20110190382 Treatment of Cancer by Inhibition of IGFBPs and Clusterin |
| 08/04/2011 | US20110190380 Methods for delivery of sirna to bone marrow cells and uses thereof |
| 08/04/2011 | US20110190375 Compositions comprising cmyc sirna and methods of use thereof |
| 08/04/2011 | US20110190374 Methods of treating a meiotic kinesin associated disease |
| 08/04/2011 | US20110190370 Modulation of hif1(alpha) and hif2(alpha) expression |
| 08/04/2011 | US20110190368 Organosulfur Compounds, a Method of Making Organosulfur Compounds and their Use for Inhibiting the Growth of Tumour Cells |
| 08/04/2011 | US20110190366 Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety |
| 08/04/2011 | US20110190363 Liquid formulations of bendamustine |
| 08/04/2011 | US20110190355 Heterocyclic indazole derivatives |
| 08/04/2011 | US20110190342 Glycine b antagonist |
| 08/04/2011 | US20110190341 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors |
| 08/04/2011 | US20110190340 Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives |
| 08/04/2011 | US20110190339 6-substituted isoquinolines and isoquinolinones |
| 08/04/2011 | US20110190337 Substituted pyrazolopyridines, compositions containing them, method for the production thereof, and their use |
| 08/04/2011 | US20110190334 Heterocyclic Sulfonamide Derivatives |
| 08/04/2011 | US20110190328 Acid addition salts of (3,5-bis trifluoromethyl)-n-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide |
| 08/04/2011 | US20110190326 Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions |
| 08/04/2011 | US20110190325 Compounds, their syntheses, and thier uses |
| 08/04/2011 | US20110190323 Cortistatin analogues and syntheses thereof |
| 08/04/2011 | US20110190321 Predictive marker for egfr inhibitor treatment |
| 08/04/2011 | US20110190319 Substituted heteroaryl fused derivatives as pi3k inhibitors |
| 08/04/2011 | US20110190318 Pharmaceutical dosage form for immediate release of an indolinone derivative |
| 08/04/2011 | US20110190315 Indoline scaffold shp-2 inhibitors and cancer treatment method |
| 08/04/2011 | US20110190312 Combinations Comprising Epothilones and Protein Tyrosine Kinase Inhibitors and Pharmaceutical Uses Thereof |
| 08/04/2011 | US20110190311 Use of cdk inhibitor for the treatment of glioma |
| 08/04/2011 | US20110190310 Hypoxia Activated Drugs Of Nitrogen Mustard Alkylators |
| 08/04/2011 | US20110190308 Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| 08/04/2011 | US20110190306 Inhibitors of PLK |
| 08/04/2011 | US20110190305 Optically Pure Diastereomers of 10-Propargyl-10-Deazaaminopterin and Methods of Using Same |
| 08/04/2011 | US20110190304 Disubstituted phthalazine hedgehog pathway antagonists |
| 08/04/2011 | US20110190302 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use |
| 08/04/2011 | US20110190297 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer |
| 08/04/2011 | US20110190295 Compositions and methods for inhibition of hepatocyte growth factor receptor c-met signaling |
| 08/04/2011 | US20110190294 Novel estrogen receptor ligands |
| 08/04/2011 | US20110190293 Quinazolinone Compounds as Anticancer Agents |
| 08/04/2011 | US20110190290 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
| 08/04/2011 | US20110190289 Imidazolothiadiazoles for Use as Protein Kinase Inhibitors |
| 08/04/2011 | US20110190288 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) for use in treatment of diseases associated with a pten deficiency |
| 08/04/2011 | US20110190282 Novel vegf-2 receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 08/04/2011 | US20110190281 Sulfone substituted 2,3-dihydroimidazo [1,2-c] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis |
| 08/04/2011 | US20110190280 Thiazole And Oxazole Kinase Inhibitors |
| 08/04/2011 | US20110190275 C2-fluoro substituted piperazine linked pyrrolo[2,1-c][1,4] benzodiazepine dimers and a process for the preparation thereof |
| 08/04/2011 | US20110190272 Chemical compounds |
| 08/04/2011 | US20110190271 2,4-Pyrimidinediamine Compounds and Uses as Anti-Proliferative Agents |
| 08/04/2011 | US20110190268 Novel Benzimidazole Linked Pyrrolo[2,1-c[1,4] Benzodiazepine Hybrids as Potential Antitumour Agents and Process for the Preparation Thereof |
| 08/04/2011 | US20110190266 5,6,6a,7,8,9-HEXAHYDRO-2H-PYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) |
| 08/04/2011 | US20110190264 Compounds and compositions as kinase inhibitors |
| 08/04/2011 | US20110190261 MAPK/ERK Kinase Inhibitors |
| 08/04/2011 | US20110190258 Aryl benzylamine compounds |
| 08/04/2011 | US20110190257 Bicyclic heterocycles as mek kinase inhibitors |
| 08/04/2011 | US20110190256 Amine and Ether Compounds Which Modulate The CB2 Receptor |
| 08/04/2011 | US20110190248 Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them |
| 08/04/2011 | US20110190246 Estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring |
| 08/04/2011 | US20110190240 Nuclear factor kappa b pathway inhibitor composition and use of same |
| 08/04/2011 | US20110190239 Bmi-1 protein expression modulators |
| 08/04/2011 | US20110190237 Macrocyclic Prodrug Compounds Useful as Therapeutics |
| 08/04/2011 | US20110190233 Anionic conjugates of glycosylated bacterial metabolite |
| 08/04/2011 | US20110190227 Antagonists of Prostaglandin D2 Receptors |
| 08/04/2011 | US20110190219 Treating cancer with granulocyte-macrophage colony stimulating factor |
| 08/04/2011 | US20110190218 Bag-1 peptide that inhibits prostate cancer |
| 08/04/2011 | US20110190204 Taxane- and Taxoid-Protein Compositions |
| 08/04/2011 | US20110190203 Ophthalmic Compositions Containing A Synergistic Combination Of Two Polymers |
| 08/04/2011 | US20110190202 Prevention of Cellular Senescence in Mammals by Natural Peptide Complexes |
| 08/04/2011 | US20110190195 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |